Alain Vuong

907 total citations
25 papers, 710 citations indexed

About

Alain Vuong is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Genetics. According to data from OpenAlex, Alain Vuong has authored 25 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pediatrics, Perinatology and Child Health, 21 papers in Psychiatry and Mental health and 7 papers in Genetics. Recurrent topics in Alain Vuong's work include Pharmacological Effects and Toxicity Studies (23 papers), Epilepsy research and treatment (21 papers) and Hemoglobinopathies and Related Disorders (7 papers). Alain Vuong is often cited by papers focused on Pharmacological Effects and Toxicity Studies (23 papers), Epilepsy research and treatment (21 papers) and Hemoglobinopathies and Related Disorders (7 papers). Alain Vuong collaborates with scholars based in United States, United Kingdom and Netherlands. Alain Vuong's co-authors include Anne E. Hammer, John A. Messenheimer, Pamela S. Barrett, Toufic Fakhoury, J. Chris Sackellares, Victor Biton, Keith R. Edwards, Orrin Devinsky, Robert P. Kustra and Barry E. Gidal and has published in prestigious journals such as Neurology, PEDIATRICS and Journal of Medicinal Chemistry.

In The Last Decade

Alain Vuong

25 papers receiving 672 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Alain Vuong 564 522 101 59 56 25 710
David Weintraub 519 0.9× 514 1.0× 142 1.4× 30 0.5× 23 0.4× 13 829
Ronald C. Reed 569 1.0× 462 0.9× 190 1.9× 23 0.4× 18 0.3× 42 789
Rossella Manco 258 0.5× 243 0.5× 69 0.7× 26 0.4× 54 1.0× 19 485
E.L. Mullens 450 0.8× 406 0.8× 131 1.3× 39 0.7× 37 0.7× 5 532
J L Herranz 542 1.0× 514 1.0× 112 1.1× 22 0.4× 39 0.7× 64 708
Graham J. Schapel 377 0.7× 349 0.7× 144 1.4× 33 0.6× 27 0.5× 27 589
Assa Mayersdorf 914 1.6× 790 1.5× 289 2.9× 53 0.9× 32 0.6× 11 1.1k
Dinko Vitezić 279 0.5× 194 0.4× 147 1.5× 59 1.0× 20 0.4× 58 653
H. Bootsma 378 0.7× 282 0.5× 113 1.1× 14 0.2× 41 0.7× 12 655
Pascal Edrich 377 0.7× 343 0.7× 160 1.6× 37 0.6× 11 0.2× 13 449

Countries citing papers authored by Alain Vuong

Since Specialization
Citations

This map shows the geographic impact of Alain Vuong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Vuong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Vuong more than expected).

Fields of papers citing papers by Alain Vuong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Vuong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Vuong. The network helps show where Alain Vuong may publish in the future.

Co-authorship network of co-authors of Alain Vuong

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Vuong. A scholar is included among the top collaborators of Alain Vuong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Vuong. Alain Vuong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leroy, Robert, Anne Van Cott, Anne E. Hammer, et al.. (2014). Lamotrigine extended-release as adjunctive therapy with optional conversion to monotherapy in older adults with epilepsy. Epilepsy Research. 108(6). 1128–1136. 5 indexed citations
2.
Biton, Victor, Bassel F. Shneker, Dean K. Naritoku, et al.. (2013). Long-Term Tolerability and Safety of Lamotrigine Extended-Release: Pooled Analysis of Three Clinical Trials. Clinical Drug Investigation. 33(5). 359–364. 14 indexed citations
3.
French, Jacqueline A., Anne E. Hammer, Alain Vuong, & John A. Messenheimer. (2012). Analysis of three lamotrigine extended-release clinical trials: Comparison of pragmatic ITT and LOCF methodologies. Epilepsy Research. 101(1-2). 141–147. 3 indexed citations
4.
Bullman, Jonathan, et al.. (2011). Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers. Epilepsia. 52(7). 1351–1358. 29 indexed citations
5.
Biton, Victor, Rakesh Shukla, Yeong Yeh Lee, et al.. (2010). Adjunctive lamotrigine XR for primary generalized tonic–clonic seizures in a randomized, placebo-controlled study. Epilepsy & Behavior. 19(3). 352–358. 43 indexed citations
6.
Fakhoury, Toufic, et al.. (2008). Effects of Lamotrigine on Mood in Older Adults with Epilepsy and Co-Morbid Depressive Symptoms. Drugs & Aging. 25(11). 955–962. 26 indexed citations
7.
Labiner, David M., Alan B. Ettinger, Toufic Fakhoury, et al.. (2008). Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy. Epilepsia. 50(3). 434–442. 57 indexed citations
8.
Holmes, Gregory L., Raj D. Sheth, Bryan Philbrook, et al.. (2008). Lamotrigine monotherapy for newly diagnosed typical absence seizures in children. Epilepsy Research. 82(2-3). 124–132. 30 indexed citations
9.
Kustra, Robert P., et al.. (2008). Depressive Symptoms in Epilepsy. Drugs. 68(11). 1493–1509. 49 indexed citations
10.
11.
Baumann, Robert J., Toufic Fakhoury, Robert P. Kustra, et al.. (2007). Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy. Current Medical Research and Opinion. 23(10). 2461–2465. 5 indexed citations
12.
Fakhoury, Toufic, et al.. (2006). Lamotrigine in patients with epilepsy and comorbid depressive symptoms. Epilepsy & Behavior. 10(1). 155–162. 28 indexed citations
13.
Sunder, Theodore R., Jerry McKee, Anne E. Hammer, & Alain Vuong. (2006). Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation. Current Medical Research and Opinion. 22(4). 693–702. 5 indexed citations
14.
McKee, Jerry, et al.. (2006). Adjunctive Lamotrigine for Refractory Epilepsy in Adolescents with Mental Retardation. Journal of Child Neurology. 21(5). 372–379. 11 indexed citations
15.
Gidal, Barry E., Tsunenobu Tamura, Anne E. Hammer, & Alain Vuong. (2005). Blood homocysteine, folate and Vitamin B-12 concentrations in patients with epilepsy receiving lamotrigine or sodium valproate for initial monotherapy. Epilepsy Research. 64(3). 161–166. 33 indexed citations
16.
Sale, Mark, Victor Biton, Alain Vuong, et al.. (2004). A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy. Epilepsy & Behavior. 6(1). 63–70. 6 indexed citations
17.
Fakhoury, Toufic, Anne E. Hammer, Alain Vuong, & John A. Messenheimer. (2004). Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy. Epilepsy & Behavior. 5(4). 532–538. 16 indexed citations
18.
Hammer, Anne E., et al.. (2003). Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy. Epilepsy & Behavior. 4(6). 659–666. 45 indexed citations
19.
20.
Edwards, Keith R., J. Chris Sackellares, Alain Vuong, Anne E. Hammer, & Pamela S. Barrett. (2001). Lamotrigine Monotherapy Improves Depressive Symptoms in Epilepsy: A Double-Blind Comparison with Valproate. Epilepsy & Behavior. 2(1). 28–36. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Weintraub Breakdown of academic impact, for papers by Ronald C. Reed Breakdown of academic impact, for papers by Rossella Manco Breakdown of academic impact, for papers by E.L. Mullens Breakdown of academic impact, for papers by J L Herranz Breakdown of academic impact, for papers by Graham J. Schapel Breakdown of academic impact, for papers by Assa Mayersdorf Breakdown of academic impact, for papers by Dinko Vitezić Breakdown of academic impact, for papers by H. Bootsma Breakdown of academic impact, for papers by Pascal Edrich
Rankless by CCL
2026